LOGIN
Liposomal Bupivacaine Vs Conventional Bupivacaine After Total Knee Arthroplasty
August 2024
Liposomal Bupivacaine Vs Conventional Bupivacaine After Total Knee Arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
A prospective, randomized trial of liposomal bupivacaine compared to conventional bupivacaine on pain control and postoperative opioid use in adults receiving adductor canal blocks for total knee arthroplasty.
Arthroplasty . 2024 Feb 1;6(1):6.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Eighty patients undergoing total knee arthroplasty were randomized to receive either liposomal bupivacaine (n=40) or conventional bupivacaine (n=40) in adductor canal blocks. The primary outcome of interest was pain scores within 72 hours postoperatively. Secondary outcomes included opioid consumption and length of hospital stay. Outcomes were assessed over a period of 72 hours post-surgery. Overa...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.